Ra. Mesa et al., HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND PULMONARY-HYPERTENSION - 2NEW CASES AND A REVIEW OF 86 REPORTED CASES, Mayo Clinic proceedings, 73(1), 1998, pp. 37-45
In this article, we describe pulmonary hypertension in two men (31 and
43 years of age) with human immunodeficiency virus (HIV) infection wh
o were examined at Mayo Clinic Rochester, Among 88 reported cases (inc
luding the two current ones) of HIV-or acquired immunodeficiency syndr
ome (AIDS)-associated pulmonary hypertension, 61% were male; the age r
ange was 2 to 56 years (mean, 32). Dyspnea was the usual initial sympt
om. Of the 74 patients in whom pulmonary artery pressure was' recorded
or calculated by echocardiography, systolic pressures ranged from 49
to 118 mm Hg (mean, 68). Of the 33 cases in which lung tissue was eval
uated microscopically, 28 (85%) were of the plexogenic variant of pulm
onary arterial hypertension, Of the other five cases examined histolog
ically, three consisted of thrombotic pulmonary arteriopathy (one was
due to recurrent thromboembolism, and the other two were due to in sit
u thrombosis), and two were of pulmonary venoocclusive disease. No cor
relation existed between either CD4 counts or a history of pulmonary i
nfections and the development of pulmonary hypertension, In 15 of the
88 patients (17%), confounding factors for hypertensive pulmonary vasc
ular disease were present, including coexisting liver disease in 13 an
d coagulation abnormalities in 2, In 83% of the patients, the developm
ent of pulmonary hypertension seems to have been related primarily to
the chronic HIV infection, Pulmonary hypertension was more rapidly pro
gressive in patients with HIV or AIDS than in those with primary pulmo
nary hypertension; the reported time intervals between onset of sympto
ms and diagnosis were 6 months and 30 months, respectively, The 1-year
survival rate for patients with HIV and pulmonary hypertension was 51
%, based on the follow-up data compiled from the 63 patients in whom i
t was described; this compares with a 1-year survival rate of 68% for
patients with primary pulmonary hypertension, Death was considered a d
irect consequence of pulmonary hypertension in 29 (76%) of the 38 fata
l cases.